ARROWHEAD PHARMACEUTICALS
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
ARROWHEAD PHARMACEUTICALS
Industry:
Biotechnology Health Care Nanotechnology Pharmaceutical
Founded:
1989-01-01
Address:
Pasadena, California, United States
Country:
United States
Website Url:
http://www.arrowheadpharma.com
Total Employee:
501+
Status:
Active
Contact:
(626) 304-3400
Total Funding:
899.88 M USD
Technology used in webpage:
Domain Not Resolving Euro IPv6 Cloudflare Hosting Microsoft Microsoft Azure Akamai Hosted Microsoft Azure US North Region
Similar Organizations
Adverum Biotechnologies
Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.
Artivion
Artivion is a biological medical device company, which has been focused on the development of implantable biological.
Windtree Therapeutics
Windtree is a clinical-stage focused on developing novel surfactant therapies for respiratory diseases and other potential applications.
Exscientia
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
LifeLens Technologies
LifeLens Technology is a biotechnology company that leads in innovative next generation treatment devices for personal health monitoring.
Novavax
Novavax is a clinical-stage biotechnology company focused on the discovery and development of innovative vaccines.
Telix Pharmaceuticals
Telix Pharmaceuticalsis a clinical-stage biotechnology company focused on the development of diagnostic and therapeutic products.
Vaxart
Vaxart is a biotechnology company that develops vaccine technology for the treatment of infectious diseases.
Verona Pharma
Verona Pharma is a biotechnology company dedicated to discovering new drugs for the treatment of chronic respiratory diseases.
Zealand Pharma
Zealand Pharma is a biotechnology company that offers scientific expertise in turning peptides into medicines.
Current Advisors List
Board_member
2019-12-01
Advisor
Board_member
Board_member
Advisor
Board_member
Advisor
Advisor
Current Employees Featured
Bruce Given Chief Operating Officer @ Arrowhead Pharmaceuticals
Chief Operating Officer
2011-10-01
Curt Bradshaw Chief Scientific Officer @ Arrowhead Pharmaceuticals
Chief Scientific Officer
James Hassard Chief Commercial Officer @ Arrowhead Pharmaceuticals
Chief Commercial Officer
Ken Myszkowski Chief Financial Officer @ Arrowhead Pharmaceuticals
Chief Financial Officer
2009-11-01
Christopher Anzalone President & CEO @ Arrowhead Pharmaceuticals
President & CEO
2007-01-01
Founder
Stock Details
Investors List
Silence Therapeutics
Silence Therapeutics investment in Post-IPO Equity - Arrowhead Pharmaceuticals
OrbiMed
OrbiMed investment in Post-IPO Equity - Arrowhead Pharmaceuticals
RA Capital Management
RA Capital Management investment in Post-IPO Equity - Arrowhead Pharmaceuticals
York Capital Management
York Capital Management investment in Post-IPO Equity - Arrowhead Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2011-01-18 | Calando Pharmaceuticals | Arrowhead Pharmaceuticals investment in Venture Round - Calando Pharmaceuticals | 1000 K USD |
| 2006-04-04 | Calando Pharmaceuticals | Arrowhead Pharmaceuticals investment in Venture Round - Calando Pharmaceuticals | 10 M USD |
Official Site Inspections
http://www.arrowheadpharma.com Semrush global rank: 1.56 M Semrush visits lastest month: 15.24 K
Unable to get host informations!!!
More informations about "Arrowhead Pharmaceuticals"
Arrowhead Pharmaceuticals - Wikipedia
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California. Arrowhead’s products in development act through RNA interference …See details»
Investors | Arrowhead Pharmaceuticals Inc.
The Investor Relations website contains information about Arrowhead Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Corporate Headquarters - Arrowhead Pharmaceuticals, Inc.
© 2025 Arrowhead Pharmaceuticals, Inc.See details»
About Us | Arrowhead Pharmaceuticals
The RNAi Difference. Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable suppression of target genes. RNAi is a mechanism present in living …See details»
Arrowhead Pharmaceuticals - LinkedIn
Arrowhead Pharmaceuticals | 51,967 followers on LinkedIn. At Arrowhead Pharmaceuticals we are breaking the mold of medicine. We are pushing the boundaries of therapeutic development …See details»
Arrowhead Pharmaceuticals Information - RocketReach
As a company we harness collaboration and innovation to rapidly advance drugs from discovery to the clinic. All applicants: Please be aware of employment scams using Arrowhead’s name …See details»
Arrowhead Pharmaceuticals - Crunchbase Company Profile
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.See details»
Press Release Details - ir.arrowheadpharma.com
Nov 26, 2024 - Upon closing, Arrowhead will receive $825 million immediately, including an upfront payment and an equity investment at a 35% premium, and will receive an additional …See details»
Arrowhead Pharmaceuticals Launches on Rare Disease Day New
The Foundation operates as an all-volunteer organization alongside a medical advisory board of specialists working to advance future treatments. In Spring 2025, the Foundation will have …See details»
Arrowhead Pharmaceuticals, Inc. (LON:0HI3) Company Profile
Jan 24, 2025 Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company’s product pipeline includes Plozasiran, …See details»
Arrowhead Pharmaceuticals Appoints Victoria Vakiener to Board of ...
PASADENA, Calif.–(BUSINESS WIRE)–May 2, 2022– Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that the board of directors appointed veteran …See details»
Events & Presentations - Arrowhead Pharmaceuticals Inc.
The Investor Relations website contains information about Arrowhead Pharmaceuticals Inc.'s business for stockholders, potential investors, and financial analysts.See details»
Press Release Details - Arrowhead Pharmaceuticals Inc.
Jul 17, 2023 PASADENA, Calif.--(BUSINESS WIRE)--Jul. 17, 2023-- Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has filed an application for …See details»
Arrowhead Pharmaceuticals - Craft
Oct 29, 2024 Arrowhead Pharmaceuticals has 5 employees across 3 locations and $3.55 m in annual revenue in FY 2024. See insights on Arrowhead Pharmaceuticals including office …See details»
Arrowhead Pharmaceuticals Launches on Rare Disease Day New …
PASADENA, Calif., February 28, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) marks Rare Disease Day with the expansion of the We’ll Get There Soon campaign, initially …See details»
Partnerships | Arrowhead Pharmaceuticals
Collaboration and Licensing Extends the Reach of Our Technology . Arrowhead actively engages in collaboration and licensing agreements with leading biotechnology and pharmaceutical …See details»
Arrowhead Pharmaceuticals Presents Preclinical Data on ARO …
Feb 25, 2025 Arrowhead Pharmaceuticals, Inc. Vince Anzalone, CFA 626-304-3400 ir@arrowheadpharma.com Investors: LifeSci Advisors, LLC Brian Ritchie 212-915-2578 …See details»
Arrowhead Pharmaceuticals Announces Planned Management …
Nov 15, 2019 Bruce has been a strong contributor to the success of our R&D organization. His lasting legacy is a culture in R&D that rewards innovation and speed. ...See details»
Press Release Details - ir.arrowheadpharma.com
Feb 28, 2025 The Foundation operates as an all-volunteer organization alongside a medical advisory board of specialists working to advance future treatments. In Spring 2025, the …See details»
Arrowhead Pharmaceuticals Reports Fiscal 2025 First Quarter Results
Feb 10, 2025 – Conference Call and Webcast Today, February 10, 2025, at 4:30 p.m. ET PASADENA, Calif.–(BUSINESS WIRE)–Feb. 10, 2025– Arrowhead Pharmaceuticals, Inc. …See details»